| TACELNU CELGENE CORPORATION
2058208 16 Oct 2020 | on 12 Jan 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies. | | | TACERA PULSE AUSTCO MARKETING AND SERVICE
1777814 18 Apr 2016 | on 18 Sep 2018 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computerized control system for use in communications and retrieval of information relative to individual patients in hospitals and other health care facilities. | | | TACERA AUSTCO MARKETING AND SERVICE
1777815 18 Apr 2016 | on 26 Mar 2019 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computerized control system for use in communications and retrieval of information relative to individual patients in hospitals and other health care facilities. | | | TACEBEROL AURORA CANNABIS ENTERPRISES INC.
1742008 12 Aug 2015 | on 23 Sep 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical cannabis oil in edible pills. | | | TACETRYN MERCK SHARP & DOHME CORP.
1610536 18 Jan 2013 | on 10 Feb 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use namely for the treatment of cancer. | | | TACEO DAEWOO MOTOR CO. LTD.
837882 27 Feb 1997 | ABANDONED - SECTION 38(7) on 06 Oct 1999 | Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Automobiles; sports cars; vans; electric vehicles, namely electric automobiles; ambulances; buses; trucks; bicycles; motorcycles; tires. | |